Jennifer Levin Carter M.D.

Jennifer Levin Carter MD, MPH, MBA has a diverse work experience in the healthcare and biotech industry. Jennifer is currently the Founder and CEO of Medzown, a company that specializes in Precision Medicine Management. Prior to this, they were also the Founder and CEO of a company in stealth, where details about the company are undisclosed.

Jennifer has also worked as a Venture Partner at Sandbox Industries, where they focused on investing in technologies that drive lasting change in healthcare. Jennifer was a Senior Strategic Advisor at Transparency Life Sciences and played a pivotal role as a Co-founder and Board Member at Xsphera Biosciences Inc.

Furthermore, Jennifer has served as a Board Member of the Target Cancer Foundation and a Member of the Directors Advisory Board at Yale University's Smilow Cancer Hospital. Jennifer has also been a Board Member of OncoCyte Corp and a Managing Director of The Blue Venture Fund.

In addition to their roles in various companies, Jennifer has provided their expertise as a Board Member and Senior Advisor at eCaring. Overall, Jennifer Levin Carter MD, MPH, MBA has an extensive background in the healthcare industry and has made significant contributions through their leadership and advisory roles.

Jennifer Levin Carter MD, MPH, MBA has a Bachelor of Science degree in Molecular Biophysics and Biochemistry from Yale University. Jennifer then obtained a medical degree from Harvard Medical School. Jennifer furthered their education by completing a Masters of Public Health degree with a focus on Health Policy and Management at Harvard T.H. Chan School of Public Health. Jennifer recently completed their MBA from MIT Sloan School of Management.